## Background: Risk factors for recurrence after resection of hepatitis b virus (hbv)-related hepatocellular carcinoma (hcc) require more precise definition. ## Methods: Forty patients who underwent liver resection for hbv-related hcc were studied. their clinical findings, laboratory data (includ
✦ LIBER ✦
Interferon-α therapy after curative resection prevents early recurrence and improves survival in patients with hepatitis B virus-related hepatocellular carcinoma
✍ Scribed by Li-Shuai Qu; Fei Jin; Xiao-Wu Huang; Xi-Zhong Shen
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 123 KB
- Volume
- 102
- Category
- Article
- ISSN
- 0022-4790
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Effect of viral status on recurrence aft
✍
Shoji Kubo; Kazuhiro Hirohashi; Hiromu Tanaka; Tadashi Tsukamoto; Taichi Shuto;
📂
Article
📅
2000
🏛
John Wiley and Sons
🌐
English
⚖ 94 KB
👁 3 views
P48 is a predictive marker for outcome o
✍
Yong-Bing Qian; Ju-Bo Zhang; Wei-Zhong Wu; Hong-Bin Fang; Wei-Dong Jia; Peng-Yua
📂
Article
📅
2006
🏛
John Wiley and Sons
🌐
English
⚖ 224 KB
👁 1 views
Interferon-α and 5-fluorouracil combinat
✍
Hiroaki Nagano; Atsushi Miyamoto; Hiroshi Wada; Hideo Ota; Shigeru Marubashi; Yu
📂
Article
📅
2007
🏛
John Wiley and Sons
🌐
English
⚖ 135 KB
## Abstract ## BACKGROUND. The authors reported previously the beneficial effects of interferon (IFN)‐α/5‐fluorouracil (5‐FU) combination therapy for patients with advanced hepatocellular carcinoma (HCC) who have tumor thrombi in the major portal branches. In this report, the authors describe the